Medication info
Astrotin Tablets 20 mg (Rosuvastatin Calcium)

Astrotin Tablets 20 mg (Rosuvastatin Calcium)

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium›20.8mg / 1 tablet
Manufacturer / importer
SK Chemical Co., Ltd.
Appearance
Pink round film-coated tablets
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201001030 · Approved 2010.01.29 · Insurance code 644703340

Summary

Main use
Treats dyslipidemia, prevents cardiovascular disease, and slows the progression of atherosclerosis
Who takes it
Adults · Children
Adult dose
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The starting dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which is sufficient for most patients. The maintenance dose should be appropriately adjusted at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response, and may be increased up to a maximum of 20 mg daily. 3. Elderly patients : No dosage adjustment is necessary. 4. Patients with renal impairment : No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment : No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race : Because systemic exposure to this medicine is increased in Asian patients, the recommended starting dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy : The recommended starting dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of this medicine is contraindicated in some of these patients.
Child dose
2. Pediatric patients with heterozygous familial hypercholesterolemia (ages 10 to 17 years): The usual dosage range is 5 mg to 20 mg once daily. Maximum daily dose: 20 mg (There are no clinical data on administering doses greater than 20 mg to pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Children under 10 years of age: Safety and efficacy have not been established.

Ingredients

Manufacturer
SK Chemical Co., Ltd.

Efficacy & effects

Treats dyslipidemia, prevents cardiovascular disease, and slows the progression of atherosclerosis

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • excess LDL cholesterol
  • dysbetalipoproteinemia
  • cardiovascular disease risk factors
  • hypertension
  • low HDL cholesterol
  • smoking
View approved original text

This medication is used as an adjunct when diet and exercise alone do not adequately control primary hypercholesterolemia and mixed dyslipidemia patients. It is also used as an adjunct therapy in patients with homozygous familial hypercholesterolemia along with dietary therapy or LDL apheresis. This medication lowers total cholesterol and LDL cholesterol levels in hypercholesterolemic patients to the target range, delaying the progression of atherosclerosis. It may also be used as an adjunct to dietary therapy in pediatric patients aged 10 to 17 years who meet specific criteria for heterozygous familial hypercholesterolemia. It also serves as an adjunct to dietary therapy for patients with primary dysbetalipoproteinemia. Furthermore, it helps to improve cardiovascular health by reducing the risk of stroke, myocardial infarction, and coronary revascularization in adult patients at high risk for cardiovascular disease.

How to take

Adult dose

1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The starting dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which is sufficient for most patients. The maintenance dose should be appropriately adjusted at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response, and may be increased up to a maximum of 20 mg daily. 3. Elderly patients : No dosage adjustment is necessary. 4. Patients with renal impairment : No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment : No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race : Because systemic exposure to this medicine is increased in Asian patients, the recommended starting dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy : The recommended starting dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of this medicine is contraindicated in some of these patients.

Child dose

2. Pediatric patients with heterozygous familial hypercholesterolemia (ages 10 to 17 years): The usual dosage range is 5 mg to 20 mg once daily. Maximum daily dose: 20 mg (There are no clinical data on administering doses greater than 20 mg to pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Children under 10 years of age: Safety and efficacy have not been established.

Precautions

This drug should not be administered to certain patients. For example, patients who are allergic to this drug or have liver dysfunction, muscular disorders, severe renal impairment, or women who are pregnant or breastfeeding should not use it. Additionally, this medication may affect muscles, and symptoms such as myalgia or muscle weakness may occur, so caution is required. Patients with renal impairment, hypothyroidism, a history of genetic muscular disorders, the elderly, and alcohol abusers should consult a healthcare professional before taking this medication. Regular liver function tests must be performed while taking this drug, and if symptoms such as myalgia, fatigue, or fever occur, immediate medical advice should be sought. Furthermore, muscle damage markers may not be accurate after strenuous exercise, so caution is advised. This medication may interact with other drugs, so it is essential to inform your healthcare provider of any current medications. Co-administration with certain medications may increase the blood concentration of this drug, raising the risk of muscle damage. Women planning to become pregnant or those who may become pregnant should use appropriate contraceptive methods and discontinue the drug immediately if pregnancy occurs. It is also safer for breastfeeding women not to take this medication. There is no specific antidote for overdose; therefore, symptomatic treatment should be received while monitoring liver function and muscle enzyme levels. Lastly, this medication may rarely cause various side effects such as liver dysfunction, neurological abnormalities, and skin rashes, so it is important to consult a healthcare provider immediately if any abnormal symptoms arise.

Side effects

Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug eruptions resembling lichen planus, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, arthralgic pain, fatigue, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, systemic pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air or moisture. Additionally, it is best to store the medication at room temperature between 1 to 30 degrees Celsius, avoiding extremes of heat or cold.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.